Estrella Immunopharma, Inc.
ESLA
$0.7936
-$0.0428-5.12%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -91.88% | 68.02% | 77.79% | 214.11% | 640.87% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 215.27% | -- | 7,712.20% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -91.83% | 61.84% | 203.41% | 228.04% | 815.29% |
|
|
|||||
| Total Current Assets | -91.83% | 61.84% | 203.41% | 228.04% | 815.29% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -86.34% | 47.08% | 178.39% | 209.31% | 782.33% |
|
|
|||||
| Total Accounts Payable | -99.95% | -- | -- | -98.21% | 440.43% |
| Total Accrued Expenses | 17.21% | -98.47% | 2,568.57% | 62.96% | 131,752.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -83.33% | -81.82% | -89.66% | -81.48% | -8.05% |
| Total Finance Division Other Current Liabilities | -99.15% | -95.35% | -85.16% | 104.13% | 3,873.35% |
| Total Other Current Liabilities | -99.15% | -95.35% | -85.16% | 104.13% | 3,873.35% |
| Total Current Liabilities | -82.70% | -98.15% | -98.07% | -91.14% | 816.99% |
|
|
|||||
| Total Current Liabilities | -82.70% | -98.15% | -98.07% | -91.14% | 816.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -82.70% | -98.15% | -98.08% | -91.20% | 799.05% |
|
|
|||||
| Common Stock & APIC | 0.00% | 5,309.91% | 6,932.41% | 9,945.05% | 17,486.15% |
| Retained Earnings | -62.72% | -59.99% | -64.42% | -124.54% | -255.06% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -92.59% | 136.39% | 193.21% | 239.73% | 363.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -92.59% | 136.39% | 193.21% | 239.73% | 363.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -92.59% | 163.38% | 306.49% | 713.13% | 755.06% |
|
|
|||||